( NASDAQ-NMS:CPIX )

News from Cumberland Pharmaceuticals Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 07, 2017, 08:15 ET Caldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the publication of a multicenter clinical study demonstrating that Caldolor®...


Jan 30, 2017, 08:15 ET U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Jan 16, 2017, 08:15 ET Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased to announce the addition of Kenneth J. Krogulski, CFA to its Board of Directors. He is...


Jan 09, 2017, 09:30 ET Cumberland Pharmaceuticals and Clinigen Enter Exclusive U.S. Commercialization Agreement For Totect®

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company and Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global...


Nov 16, 2016, 08:00 ET Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products

Cumberland Pharmaceuticals (NASDAQ: CPIX), a U.S. specialty pharmaceutical company has entered into an Agreement to acquire the exclusive U.S....


Nov 01, 2016, 16:05 ET Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2016 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Oct 25, 2016, 16:05 ET Cumberland Pharmaceuticals To Announce Third Quarter 2016 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2016 financial results after the market closes on...


Sep 26, 2016, 08:30 ET Cumberland Pharmaceuticals Launches Promotion Of Ethyol® In The United States For Oncology Patient Support

NASHVILLE, Tenn., Sept. 26, 2016 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), announced today that it has launched the U.S....


Sep 14, 2016, 16:05 ET Cumberland Pharmaceuticals Announces New Program To Develop Portaban™ For Portal Hypertension

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), today announced the initiation of a new Phase II clinical program of Portaban™ for...


Aug 23, 2016, 16:05 ET Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol® (amifostine) For Oncology Patient Support

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for...


Aug 02, 2016, 16:05 ET Cumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Jul 26, 2016, 16:05 ET Cumberland Pharmaceuticals To Announce Second Quarter 2016 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release second quarter 2016 financial results after the market...


Jul 18, 2016, 09:00 ET Cumberland Pharmaceuticals To Participate In Avondale Partners' 4th Annual Healthcare Conference

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for...


May 10, 2016, 16:05 ET Cumberland Pharmaceuticals Reports First Quarter 2016 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


May 10, 2016, 07:00 ET Cumberland Pharmaceuticals and Clinigen Group enter into exclusive U.S. commercialization agreement for oncology support drug Ethyol®

 Cumberland Pharmaceuticals Inc. ('Cumberland', NASDAQ: CPIX), a U.S. specialty pharmaceutical company and Clinigen Group plc ('Clinigen', AIM:...


May 03, 2016, 16:15 ET Cumberland Pharmaceuticals To Announce First Quarter 2016 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2016 financial results after the market closes on...


Apr 27, 2016, 08:00 ET Cumberland Pharmaceuticals Announces New Program To Develop Vasculan™ For Systemic Sclerosis

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for...


Mar 24, 2016, 07:30 ET Caldolor® Launched For The Treatment Of Pain And Fever In Children

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) a specialty pharmaceutical company, today announced the launch of Caldolor® (ibuprofen)...


Mar 03, 2016, 16:05 ET Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2015 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Feb 25, 2016, 16:05 ET Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2015 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2015 financial results after the...


Feb 10, 2016, 08:30 ET Vaprisol Dose Comparison Published Supporting Its Efficacy, Safety And Pharmacokinetics

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the publication of an open label multicenter study adding to the growing body of...


Jan 25, 2016, 08:00 ET Piramal Critical Care And Cumberland Pharmaceuticals Announce Launch Of Caldolor And Vaprisol Co-Promotion

 Piramal Critical Care, an integral business unit of Piramal Enterprises Limited (NSE: PEL, BSE: 500302), and Cumberland Pharmaceuticals...


Nov 23, 2015, 16:05 ET Caldolor® Launched In Australia For Treatment Of Pain And Fever

 Cumberland Pharmaceuticals (NASDAQ: CPIX) announced today the launch of Caldolor® in Australia.  Caldolor is an intravenous...


Nov 23, 2015, 09:20 ET Caldolor Approved For Use In Pediatric Patients

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology announced the...


Nov 20, 2015, 09:20 ET Cumberland Pharmaceuticals Announces Favorable Acetadote® Patent Ruling

 On November 17, 2015, an Illinois judge issued a final ruling in favor of Cumberland Pharmaceuticals Inc. in a patent case associated with its...